Kim Hyungsoo, Kim Bu-Yeon, Soh Jae-Won, Cho Eun-Jung, Liu Jun O, Youn Hong-Duk
Department of Biochemistry and Molecular Biology, Cancer Research Institute, Interdisciplinary Program in Genetic Engineering, Seoul National University College of Medicine, 28 Yongon-dong, Chongro-gu, Seoul 110-799, Republic of Korea.
Biochem Biophys Res Commun. 2006 Sep 29;348(3):950-6. doi: 10.1016/j.bbrc.2006.07.167. Epub 2006 Aug 4.
Despite the involvement in diverse physiological process and pleiotropic expression profile, the molecular functions of Nur77 are not likely to be fully elucidated. From the effort to find a novel function of Nur77, we detected molecular interaction between Nur77 and PKC. Details of interaction revealed that C-terminal ligand binding domain (LBD) of Nur77 specifically interacted with highly conserved glycine-rich loop of PKC required for catalytic activity. This molecular interaction resulted in inhibition of catalytic activity of PKCtheta by Nur77. C-terminal LBD of Nur77 is sufficient for inhibiting the phosphorylation of substrate by PKCtheta. Ultimately, inhibition of catalytic activity by Nur77 is deeply associated with repression of PKC-mediated activation of AP-1 and NF-kappaB. Therefore, these findings demonstrate a novel function of Nur77 as a PKC inhibitor and give insights into molecular mechanisms of various Nur77-mediated physiological phenomena.
尽管Nur77参与多种生理过程并具有多效性表达谱,但其分子功能仍不太可能被完全阐明。在寻找Nur77新功能的过程中,我们检测到了Nur77与蛋白激酶C(PKC)之间的分子相互作用。相互作用的细节表明,Nur77的C末端配体结合结构域(LBD)与PKC催化活性所需的高度保守的富含甘氨酸环特异性相互作用。这种分子相互作用导致Nur77抑制PKCθ的催化活性。Nur77的C末端LBD足以抑制PKCθ介导的底物磷酸化。最终,Nur77对催化活性的抑制与PKC介导的AP-1和核因子κB(NF-κB)激活的抑制密切相关。因此,这些发现证明了Nur77作为PKC抑制剂的新功能,并深入了解了各种Nur77介导的生理现象的分子机制。